under the trade names Epogen, and Procrit (sold by Johnson & Johnson). TKT's GA-EPO (Dynepo) differs from Epogen in the way that it is made and possibly in carbohydrate structure. GA-EPO is made ...

Amgen's process patent describes the production of its erythropoietin product, Epogen, by expression of the cloned human EPO cDNA sequence, by placing the simian viral DNA promoter (SV40 ...

EPO, erythropoietin; Hb, hemoglobin; s.c., subcutaneous; t.i.w., three times a week. a Hb response is defined as an Hb increase of 2 g/dl from baseline if not stated otherwise. b Hb target level ...

The World Anti-Doping Agency (WADA) is pleased to share positive insights from a study it recently published examining the ...

Administration of recombinant human erythropoietin (rHumanEPO) improves sporting performance and hence is frequently subject to abuse by athletes, although rHumanEPO is prohibited by the WADA.

Originally blood tests were introduced for medical reasons and for limiting misuse of recombinant human erythropoietin (rHuEPO). In this way it became possible to prevent athletes with haematocrit ...

Furthermore, commercialization patterns for erythropoietin biosimilars, readily available reimbursements, favorable government regulations, and awareness regarding benefits of EPO therapeutics ...

For cancer patients, anemia can be a debilitating problem that negatively influences their overall quality of life and worsens their prognosis. The condition is caused either by the cancer itself ...